IDNA 24.61 iShares Genomics Immunology and Healthcare ETF
| Range: | 17.33-25.697 | Vol Avg: | 26210 | Last Div: | 0.28 | Changes: | 0.09 |
| Beta: | 1.13 | Cap: | 0.14B | Currency: | USD | Exchange: | AMEX |
| Sector: | Financial Services | IPO: | Fri Jun 14 2019 | Empoloyees: | |||
| CUSIP: | 46435U192 | CIK: | 0001100663 | ISIN: | US46435U1925 | Country: | US |
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow